150 related articles for article (PubMed ID: 35100851)
61. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
[TBL] [Abstract][Full Text] [Related]
62. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.
Simon D; Goretzki PE; Witte J; Röher HD
World J Surg; 1996 Sep; 20(7):860-6; discussion 866. PubMed ID: 8678963
[TBL] [Abstract][Full Text] [Related]
63. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
[TBL] [Abstract][Full Text] [Related]
64. Controversy: For or against thyroid lobectomy in>1cm differentiated thyroid cancer?
Menegaux F; Lifante JC
Ann Endocrinol (Paris); 2021 Apr; 82(2):78-82. PubMed ID: 33757822
[TBL] [Abstract][Full Text] [Related]
65. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
66. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
67. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
[TBL] [Abstract][Full Text] [Related]
68. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
[TBL] [Abstract][Full Text] [Related]
69. Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer.
Cherella CE; Richman DM; Liu E; Frates MC; Modi BP; Zendejas B; Smith JR; Barletta JA; Hollowell ML; Wassner AJ
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4242-e4250. PubMed ID: 33780538
[TBL] [Abstract][Full Text] [Related]
70. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
[TBL] [Abstract][Full Text] [Related]
71. Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: experience of an endocrine surgery center in an iodine-deficient region.
Duren M; Yavuz N; Bukey Y; Ozyegin MA; Gundogdu S; Açbay O; Hatemi H; Uslu I; Onsel C; Aksoy F; Oz F; Unal G; Duren E
World J Surg; 2000 Nov; 24(11):1290-4. PubMed ID: 11038196
[TBL] [Abstract][Full Text] [Related]
72. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
73. Selective treatment of differentiated thyroid carcinoma.
Gemsenjäger E; Heitz PU; Martina B
World J Surg; 1997 Jun; 21(5):546-51; discussion 551-2. PubMed ID: 9204746
[TBL] [Abstract][Full Text] [Related]
74. Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer.
Giuffrida D; Giuffrida R; Puliafito I; Vella V; Memeo L; Puglisi C; Regalbuto C; Pellegriti G; Forte S; Belfiore A
Int J Surg Oncol; 2019; 2019():2715260. PubMed ID: 31737363
[TBL] [Abstract][Full Text] [Related]
75. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
Tsui KP; Kwan WY; Chow TL
Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
[TBL] [Abstract][Full Text] [Related]
76. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer.
Barney BM; Hitchcock YJ; Sharma P; Shrieve DC; Tward JD
Head Neck; 2011 May; 33(5):645-9. PubMed ID: 20687168
[TBL] [Abstract][Full Text] [Related]
77. Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer.
McCoy KL; Carty SE; Armstrong MJ; Seethala RR; Ohori NP; Kabaker AS; Stang MT; Hodak SP; Nikiforov YE; Yip L
J Am Coll Surg; 2012 Oct; 215(4):546-54. PubMed ID: 22766226
[TBL] [Abstract][Full Text] [Related]
78. Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.
Kuo EJ; Thi WJ; Zheng F; Zanocco KA; Livhits MJ; Yeh MW
Thyroid; 2017 Dec; 27(12):1544-1549. PubMed ID: 29113553
[TBL] [Abstract][Full Text] [Related]
79. Surgical treatment of differentiated thyroid carcinoma in children.
Bingöl-Koloğlu M; Tanyel FC; Senocak ME; Büyükpamukçu N; Hiçsönmez A
Eur J Pediatr Surg; 2000 Dec; 10(6):347-52. PubMed ID: 11215773
[TBL] [Abstract][Full Text] [Related]
80. The Prospective Implementation of the 2015 ATA Guidelines and Modified ATA Recurrence Risk Stratification System for Treatment of Differentiated Thyroid Cancer in a Canadian Tertiary Care Referral Setting.
Wu J; Hu XY; Ghaznavi S; Kinnear S; Symonds CJ; Grundy P; Parkins VM; Sharma P; Lamb D; Khalil M; Hyrcza M; Chandarana SP; Pasieka JL; Harvey A; Warshawski J; Hart R; Deutschman M; Randall DR; Paschke R
Thyroid; 2022 Dec; 32(12):1509-1518. PubMed ID: 36226405
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
